November 8, 2022
Via: PR NewswireJiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that positive results were achieved for its primary vaccination Phase II study in the Philippines and heterologous booster vaccination Phase II study in […]
May 4, 2022
Via: The Wall Street JournalModerna Inc. MRNA -1.16% said that its first-quarter revenue and profit tripled from a year earlier on higher sales of its Covid-19 vaccine and that a fall booster-shot campaign could drive continued sales gains. The biotechnology company’s revenue topped $6 […]
Industry Focus Areas, Logistics, Medical, Process
November 4, 2021
Via: The Wall Street JournalModerna Inc. has encountered supply challenges for its Covid-19 vaccine, resulting in lower-than-expected sales for the latest quarter and a reduced forecast of dose deliveries and sales for the full year. The Cambridge, Mass., company cited the complexities of shipping […]
Industry Focus Areas, Medical, Regulations
October 5, 2021
Via: The Wall Street JournalJohnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot. The Food and Drug Administration could decide on J&J’s […]
September 22, 2021
Via: The New York TimesAs President Biden convenes heads of state for a Covid-19 summit on Wednesday, pressure is growing on American drug companies — particularly Moderna, the upstart biotech firm that developed its coronavirus vaccine with billions of dollars in taxpayer money — […]
August 5, 2021
Via: The Wall Street JournalModerna Inc. said Thursday it expects people who received its two-dose Covid-19 vaccine to need a booster shot in the fall to keep strong protection against newer variants of the coronavirus. The company said its vaccine remains 90% effective against […]
June 21, 2021
Via: The Wall Street JournalModerna Inc. is adding two new production lines at the rebuilt former Polaroid plant where it manufactures its Covid-19 vaccine, part of a push to prepare for making booster shots and the future of the pandemic. At a site brimming […]
March 29, 2021
Via: Electronics WeeklyThat is nearly twice the amount of the five billion vaccine doses of all types produced across the world before the pandemic struck. Even so, it is still less than the 11.5 billion doses of Covid-19 vaccine needed to meet […]
January 5, 2021
Via: The Wall Street JournalModerna Inc. said it will be able to make at least 600 million doses of its Covid-19 vaccine this year, 100 million more than it had been projecting. The Cambridge, Mass., company also said it is making investments and adding […]
November 25, 2020
Via: Transport TopicsOil extended gains, trading at its highest level since March, on mounting optimism that recent breakthroughs on a COVID-19 vaccine will lead to a swift recovery in global energy demand next year. Futures in New York on Nov. 25 rose […]
November 12, 2020
Via: Transport TopicsWhen Pfizer Inc. and BioNTech SE’s COVID-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of deep-freeze airport warehouses, refrigerated vehicles and inoculation points across China. […]
June 1, 2020
Via: ReutersAs drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking to secure manufacturing capacity under its “Operation Warp Speed” program announced in May to accelerate vaccine development. “Securing more manufacturing capacity here in […]